Easy, convenient SMS messaging has generally been underutilized by the research sector of the pharmaceutical industry, with a quasi-obscure British firm as one of the rare companies that had a vision of what was possible. But ePharmaSolutions is experienced in research-oriented texting, too. It just announced a new version of its software. “Our integrations with leading clinical trial management system (CTMS) and interactive voice response system (IVRS) vendors make it simple to auto-populate study information to reduce site workload," said Steven Beales, ePharmaSolutions VP of IT. There is a news release on this hard-to-navigate page.

Quintiles will look to IT as a revenue center. A trade press story notes that Quintiles has been working closely with Oracle to make its systems more robust and clinical data more accessible. One focus of the trade press story is the Quintiles “Infosario” program, which ClinPage covered here.

Along with declining standardized test scores, the U.S. can take pride in surprising levels of public ignorance about drug safety. That’s the message from Dartmouth researchers, who polled thousands of U.S. citizens for a research project on public comprehension of the risks of medicines and the practical significance of FDA approval of new drugs. The Dartmouth professors are joining other Ivy League academics in broadly advising patients to not use new any medicines until they have been on the market for many years. Here’s a link to a story in U.S. News.

BioClinica announced a new version of its slimmed-down electronic data capture (EDC) system, intended for simpler, faster setup on smaller, less complex trials. “BioClinica Express provides new capabilities for EDC power users that make slicing and dicing incoming data fast and easy and automatically encodes medical terms within the same application,” the company says in a release.

Electronic data capture supplier OmniComm Systems and eclinical integration specialists PharmaPros announced a partnership. PharmaPros specializes in extracting and displaying clinical data in ways that facilitate trials. “Our customers will reap the benefits of this cutting-edge integration of technologies," noted Stephen Johnson, OmniComm’s president & COO. "The convergence of electronic data capture (EDC) solutions like our TrialMaster with business intelligence tools like Dataflow Manager will significantly reduce the burden put on our customers to improve clinical trial efficiency while reducing costs.” Here’s a release.

PPD named a new CEO. Consultant Raymond Hill has extensive life science experience, most recently working at IMS Health. He’s also put in time at A.T. Kearney and Booz Allen Hamilton. "With more than 20 years of experience in the life sciences arena, Ray brings keen strategic acumen as a proven leader who has grown global client services businesses in the pharmaceutical industry," said Fred Eshelman, PPD’s executive chairman. Here’s a link.

Have news? Send it to .(JavaScript must be enabled to view this email address)